These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 9559884

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pre- and postjunctional protective effect of neocuproine on the nitrergic neurotransmitter in the mouse gastric fundus.
    De Man JG, Moreels TG, De Winter BY, Herman AG, Pelckmans PA.
    Br J Pharmacol; 2001 Jan; 132(1):277-85. PubMed ID: 11156587
    [Abstract] [Full Text] [Related]

  • 4. Neocuproine potentiates the activity of the nitrergic neurotransmitter but inhibits that of S-nitrosothiols.
    De Man JG, Moreels TG, De Winter BY, Herman AG, Pelckmans PA.
    Eur J Pharmacol; 1999 Sep 24; 381(2-3):151-9. PubMed ID: 10554883
    [Abstract] [Full Text] [Related]

  • 5. Effect of thiol modulators and Cu/Zn superoxide dismutase inhibition on nitrergic relaxations in the rat gastric fundus.
    De Man JG, De Winter BY, Boeckxstaens GE, Herman AG, Pelckmans PA.
    Br J Pharmacol; 1996 Nov 24; 119(5):1022-8. PubMed ID: 8922754
    [Abstract] [Full Text] [Related]

  • 6. Comparative study of the quercetin, ascorbic acid, glutathione and superoxide dismutase for nitric oxide protecting effects in mouse gastric fundus.
    Ertuğ PU, Aydinoglu F, Goruroglu Ozturk O, Singirik E, Ögülener N.
    Eur J Pharmacol; 2013 Jan 05; 698(1-3):379-87. PubMed ID: 23085029
    [Abstract] [Full Text] [Related]

  • 7. Evidence for the interaction between nitric oxide and vasoactive intestinal polypeptide in the mouse gastric fundus.
    Ergün Y, Oğülener N.
    J Pharmacol Exp Ther; 2001 Dec 05; 299(3):945-50. PubMed ID: 11714881
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bioassay and pharmacological characterization of the nitrergic neurotransmitter.
    Boeckxstaens GE, De Man JG, De Winter BY, Moreels TG, Herman AG, Pelckmans PA.
    Arch Int Pharmacodyn Ther; 1995 Dec 05; 329(1):11-26. PubMed ID: 7639612
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lead effects on non-adrenergic non-cholinergic relaxations in the rat gastric fundus.
    Santos MR, Marchioro M, Antoniolli AR.
    Toxicol In Vitro; 2006 Feb 05; 20(1):38-42. PubMed ID: 16026961
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the pharmacological profile of S-nitrosothiols, nitric oxide and the nitrergic neurotransmitter in the canine ileocolonic junction.
    De Man JG, Boeckxstaens GE, De Winter BY, Moreels TG, Misset ME, Herman AG, Pelckmans PA.
    Br J Pharmacol; 1995 Mar 05; 114(6):1179-84. PubMed ID: 7620707
    [Abstract] [Full Text] [Related]

  • 20. Influence of superoxide dismutase inhibition on the discrimination between NO and the nitrergic neurotransmitter in the rat gastric fundus.
    Lefebvre RA.
    Br J Pharmacol; 1996 Aug 05; 118(8):2171-7. PubMed ID: 8864558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.